World Trade Factory™

Lupin announces closure of US FDA insepction of Nagpur facility with zero observations

Lupin announces closure of US FDA insepction of Nagpur facility with zero observations

Lupin has announced that the United States Food and Drug Administration's inspection of its Nagpur facility has come to a close.  In an exchange filing published on November 15, the pharma company said that the drug regulator concluded the inspection of its Nagpur Unit-1 Facility with "No Observations”.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.